{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:45:35Z","timestamp":1789202735550,"version":"build-2803163510"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:p>This cross-sectional study evaluates insurance and patient spending for the spinal muscular atrophy medications nusinersen, onasemnogene abeparvovec-xioi, and risdiplam from 2021 through 2022.<\/jats:p>","DOI":"10.1001\/jamapediatrics.2026.0641","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T15:30:22Z","timestamp":1776094222000},"page":"695","source":"Crossref","is-referenced-by-count":1,"title":["Out-of-Pocket Cost of Spinal Muscular Atrophy Gene Therapies Among Commercially Insured Patients"],"prefix":"10.1001","volume":"180","author":[{"given":"Maria","family":"Sckaff","sequence":"first","affiliation":[{"name":"Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilina C.","family":"Odouard","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeromie","family":"Ballreich","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Anderson","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana P.","family":"Socal","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"pld260009r4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.18553\/jmcp.2022.28.1.39","article-title":"Coverage of genetic therapies for spinal muscular atrophy across fee-for-service Medicaid programs.","volume":"28","author":"Ballreich","year":"2022","journal-title":"J Manag Care Spec Pharm"},{"issue":"12","key":"pld260009r5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006281.pub5","article-title":"Drug treatment for spinal muscular atrophy type I.","volume":"12","author":"Wadman","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"pld260009r1","unstructured":"Spinraza. Prescribing information. Biogen. Accessed December 1, 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/209531s013s014lbl.pdf"},{"key":"pld260009r2","unstructured":"Zolgensma. Prescribing information. Novartis Gene Therapies, Inc. Accessed December 1, 2024. https:\/\/www.fda.gov\/media\/126109\/download"},{"key":"pld260009r3","unstructured":"Evrysdi. Prescribing information. Genentech, Inc. Accessed December 1, 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/213535s013lbl.pdf"},{"key":"pld260009r6","unstructured":"Cure SMA. State of SMA 2022 Report. 2023. Accessed January 28, 2026. https:\/\/www.curesma.org\/wp-content\/uploads\/2023\/06\/9062023_State-of-SMA_vWeb.pdf"}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2847696\/jamapediatrics_sckaff_2026_ld_260009_1779464396.11917.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:00:29Z","timestamp":1780326029000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2847696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2026.0641","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}